Skip to main content

Find Clinical Trials

Home
Conditions
EGFR Overexpression

Clinical trial condition

EGFR Overexpression

Explore clinical trials studying EGFR Overexpression. Study availability and eligibility vary by location and protocol.

3 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

EGFR Overexpression trial results

Recruiting

Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors

NCT06975410

Conditions: Biliary Tract Diseases, Biliary Tract Neoplasms, Bronchial Neoplasms, +43 more
Locations: Korea University Anam Hospital Seoul, South Korea

Seoul National University Hospital Seoul, South Korea

Severance Hospital Seoul, South Korea

Samsung Medical Center Seoul, South Korea

View Trial Details

Recruiting

HER-2 B Cell Peptide Vaccine

NCT06414733

Conditions: Breast Diseases, Breast Neoplasms, Digestive System Diseases, +12 more
Locations: Indiana University Melvin & Bren Simon Comprehensive Cancer Center Indianpolis, Indiana, United States

View Trial Details

Active, Not Recruiting

A Randomized, Single Intravenous Dose, Parallel Phase I Clinical Study to Compare the Pharmacokinetic Characteristics, Safety, and Immunogenicity of HLX05 Vs. Erbitux® (Cetuximab) in Healthy Adult Male Chinese Subjects

NCT06309043

Conditions: EGFR Overexpression
Locations: Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China

View Trial Details